West Pharmaceutical Services Inc
WST· NYSE
Released Feb 13, 2025, before the open
10-K filed Feb 18, 2025, 49 days after period end · 0000105770-25-000013
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $748.80M | $732.00M | $708.70M | $730.80M |
| Net Income | $130.10M |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $137.00M |
| $103.00M |
| $147.70M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.